A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis ...

In the field of immunology, innate lymphoid cells (ILCs) have emerged as significant players within the hepatobiliary and gastrointestinal systems.

Shares of Hepion Pharmaceuticals Inc. drew heightened attention from retail traders on Monday after the company disclosed ...

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment ...

The Liver Transplant Comorbidity Index, developed from FrAILT study results, identified patients at high risk for mortality at 3 years post-liver transplant.